IRBETAN irbesartan 75mg film-coated tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

irbesartan, Quantity: 75 mg

Disponible depuis:

Medis Pharma Pty Ltd

DCI (Dénomination commune internationale):

Irbesartan

forme pharmaceutique:

Tablet, film coated

Composition:

Excipient Ingredients: lactose monohydrate; croscarmellose sodium; magnesium stearate; povidone; titanium dioxide; hypromellose; macrogol 4000

Mode d'administration:

Oral

Unités en paquet:

30s

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Irbesartan is indicated for the following: For the treatment of hypertension. For delaying the progression of renal disease in hypertensive type II diabetics with persistent micro-albuminuria (equal to or greater than 30 mg per 24 hours) or urinary protein in excess of 900 mg per 24 hours.

Descriptif du produit:

Visual Identification: White to off-white, oval shaped, biconvex, film coated tablet, debossed with "L172" on one side and "75" on the other side.; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statut de autorisation:

Licence status A

Date de l'autorisation:

2012-11-13